Displurigen
Displurigen (NSC375009) disrupts human embryonic stem cell pluripotency by targeting HSPA8. Displurigen inhibits ATPase activity of HSP70 (IC50 = 225 μM) [1].
Product Specifications
CAS Number
96156-26-2
Product Name Alternative
NSC375009
UNSPSC
12352005
Hazard Statement
H315, H319
Target
HSP
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/displurigen.html
Purity
98.48
Solubility
DMSO : 7 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C1=CC=CC(O)=C12)C=C(C3=CC=CC=C3)S2(=O)=O
Molecular Formula
C15H10O4S
Molecular Weight
286.30
Precautions
H315, H319
References & Citations
[1]Yijie Geng, et al. A Chemical Biology Study of Human Pluripotent Stem Cells Unveils HSPA8 as a Key Regulator of Pluripotency. Stem Cell Reports. 2015 Dec 8;5 (6) :1143-1154.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![5-Bromo-7-methylbenzo[b]thiophene-2-carboxylic acid](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
BNC470052-100 1x 100 µL
HCG-intact (HCGab/52), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details K0652907 1.0 µg DNA
EDA2R sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details